Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases
Background: Interferon-β (IFN-β) is an effective drug in multiple sclerosis (MS) but it may cause acute exacerbation of MS following the initiation of treatment. This study evaluated patients with rapid exacerbation of multiple sclerosis (REMS) following the initiation of IFN-β. Methods: We retrospe...
Main Authors: | Masoud Etemadifar, Amir Hossein Sarrami |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2011;volume=16;issue=12;spage=1619;epage=1622;aulast=Etemadifar |
Similar Items
-
Investigating the Occurrence of Femoral Head Avascular Necrosis in Patient with Multiple Sclerosis Treated with Interferon-Beta
by: Pegah Sadat Fatehi, et al.
Published: (2018-11-01) -
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis
by: Annette Kolb-Mäurer, et al.
Published: (2015-07-01) -
Fingolimod versus High Dose Interferon Beta-1a in Multiple Sclerosis: A Randomized Clinical Trial
by: Masoud Etemadifar, et al.
Published: (2017-02-01) -
Drug induced liver injury secondary to interferon-beta (IFN-β) in multiple sclerosis
by: V. Byrnes, et al.
Published: (2006-01-01) -
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients
by: Marco Chiarini, et al.
Published: (2020-04-01)